Prevalence of gestational diabetes mellitus, maternal obesity and associated perinatal outcomes over 10 years in an Australian tertiary maternity provider [0.03%]
澳大利亚三级产科服务机构10年间的妊娠糖尿病、产妇肥胖及其相关围生期结局的流行病学研究
J Deitch,C J Yates,P S Hamblin et al.
J Deitch et al.
Background: The International Association of Diabetes in Pregnancy Study Groups (IADPSG) gestational diabetes mellitus (GDM) criteria have been heavily scrutinised with concerns that the consequent GDM prevalence increase...
Effect of vitamin D on regression to normal glucose regulation and individual glycemic measures: A secondary analysis among participants adherent to the trial protocol in the randomized clinical trial vitamin D and type 2 diabetes (D2d) study [0.03%]
维生素D对恢复正常葡萄糖调节和个体血糖指标的影响：随机临床试验（D2d研究）中符合试验方案的参与者的二次分析
Daniel S Hsia,Jason Nelson,Ellen M Vickery et al.
Daniel S Hsia et al.
Aims: To examine the effect of vitamin D on regression to normal glucose regulation (NGR) and individual glycemic measures in the D2d study. Methods: ...
Effects of dapagliflozin on renal function in type 1 diabetes patients in the real world: A retrospective multicenter study of the KAMOGAWA-A cohort [0.03%]
达格列净对1型糖尿病患者肾脏功能影响：KAMOGAWA-A队列的回顾性多中心研究
Junya Hironaka,Hiroshi Okada,Masahide Hamaguchi et al.
Junya Hironaka et al.
Aims: This study aimed to investigate the effects of dapagliflozin on renal function of type 1 diabetes patients. Methods: This retrosp...
Metformin versus insulin for gestational diabetes: Adiposity variables and adipocytokines in offspring at age of 9 years [0.03%]
用于妊娠期糖尿病的二甲双胍与胰岛素治疗：对孩子九岁时体重变量和脂肪细胞因子的影响
Elisa Paavilainen,Harri Niinikoski,Riitta Parkkola et al.
Elisa Paavilainen et al.
Aims: To compare body composition, visceral adiposity, adipocytokines, and low-grade inflammation markers in prepubertal offspring of mothers who were treated with metformin or insulin for gestational diabetes mellitus (G...
Randomized Controlled Trial
Diabetes research and clinical practice. 2023 Aug:202:110780. DOI:10.1016/j.diabres.2023.110780 2023
Exploring the role of gut microbiota in obesity and PCOS: Current updates and future prospects [0.03%]
肠道菌群在肥胖和多囊卵巢综合征中的作用：最新研究进展及未来前景
Hui Zhang,Claudette Butoyi,Guoyue Yuan et al.
Hui Zhang et al.
Polycystic ovary syndrome (PCOS) is a common endocrine gynecological disorder, and the specific pathogenesis of PCOS has not been elucidated. Obesity is a current major public health problem, which is also vital to PCOS. It can exacerbate P...
Thomas Klein,Robert Augustin,Anita M Hennige
Thomas Klein
Glucagon-like peptide-1 receptor (GLP-1R) agonists are approved treatments for Type 2 diabetes mellitus, with liraglutide and semaglutide also approved for the treatment of obesity. The natural gut hormone oxyntomodulin is a weak dual agoni...
Longitudinal treatment patterns in patients recently diagnosed with type 2 diabetes mellitus in Catalonia [0.03%]
新诊断的二型糖尿病患者在 Catalonia 的纵向治疗模式
Dan Ouchi,Maria Giner-Soriano,Carles Vilaplana-Carnerero et al.
Dan Ouchi et al.
Aim: To investigate initial and subsequent treatments prescribed to newly diagnosed type 2 diabetes mellitus (T2DM) patients. Methods: ...
Michael Fang,Jiaqi Hu,Yein Jeon et al.
Michael Fang et al.
Aims: Data on the long-term consequences of diabetic foot disease (DFD) are scarce. We examined the association between DFD and major clinical outcomes in patients with diabetes in the general population. ...
Magnetic resonance study of visceral, subcutaneous, liver and pancreas fat changes after 12 weeks intermittent fasting in obese participants with prediabetes [0.03%]
肥胖前期患者间歇性禁食12周后腹部、皮下、肝脏和胰腺脂肪变化的磁共振研究
Dech Dokpuang,John Zhiyong Yang,Reza Nemati et al.
Dech Dokpuang et al.
Background: It is not clear whether there are differences in proportions of fat loss from visceral:subcutaneous depots by probiotic supplementation, ethnicity or sex during weight loss; or whether visceral/pancreatic fat ...
Randomized Controlled Trial
Diabetes research and clinical practice. 2023 Aug:202:110775. DOI:10.1016/j.diabres.2023.110775 2023
Incidence of diabetes mellitus in patients treated with immune checkpoint inhibitors (ICI) therapy - A comprehensive cancer center experience [0.03%]
免疫检查点抑制剂治疗患者的糖尿病发病率——一家全面癌症中心的经验报告
Zhen Zhang,Rajeev Sharma,Lamya Hamad et al.
Zhen Zhang et al.
Background: Immune checkpoint inhibitors (ICIs) have revolutionized cancer treatment and more patients are receiving ICIs than before. Although this has improved cancer care but so has the increase in the incidence of imm...